Contribution of Hypervariable Domains to the Conformation of a Broadly Neutralizing Glycoprotein 120 Epitope
- 1 July 1995
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 11 (7) , 777-781
- https://doi.org/10.1089/aid.1995.11.777
Abstract
Three of the five hypervariable domains (V1-V3) of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp120 have previously been shown to be dispensable for antigenic epitopes recognized by broadly neutralizing monoclonal antibodies. In this study, the influence of the V4 and V5 domains on an epitope recognized by a broadly neutralizing human monoclonal antibody, 1.5e, was investigated. In contrast with the V1, V2, and V3 domains of gp120, the V4 and V5 domains were found to be critical for binding to both CD4 and 1.5e. Our results suggest that V4 and V5 are in structurally less flexible regions of gp120 than V1, V2, and V3 and raises the question of whether variable domains V4 and V5 are also indispensable for other broadly neutralizing antibodies in the same class as 1.5e.Keywords
This publication has 45 references indexed in Scilit:
- Influence of Deletions in N or C Terminus of HIV-1 Glycoprotein 120 on Binding of Infectivity-Enhancing AntibodyAIDS Research and Human Retroviruses, 1994
- Distinction of human immunodeficiency virus type 1 neutralization and infection enhancement by human monoclonal antibodies to glycoprotein 120.Journal of Clinical Investigation, 1992
- A human monoclonal antibody against the CD4-binding site of HIV1 gp120 exhibits potent, broadly neutralizing activityResearch in Virology, 1991
- Importance of Hypervariable Regions of HIV-1 gp120 in the Generation of Virus Neutralizing AntibodiesAIDS Research and Human Retroviruses, 1990
- Identification of Conserved and Variant Epitopes of Human Immunodeficiency Virus Type 1 (HIV-1) gp120 by Human Monoclonal Antibodies Produced by EBV-Transformed Cell LinesAIDS Research and Human Retroviruses, 1990
- Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation.The Journal of Experimental Medicine, 1989
- Characteristics of a Neutralizing Monoclonal Antibody to the HIV Envelope GlycoproteinAIDS Research and Human Retroviruses, 1988
- Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDSCell, 1986
- Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-IIIScience, 1985
- Characterization of Envelope and Core Structural Gene Products of HTLV-III with Sera from AIDS PatientsScience, 1985